Vladimir Dobričić, PhD

Farmaceutski fakultet

Position: associate professor
Organizational unit:  Department of Pharmaceutical Chemistry
Room: 207 (Building B)
Phone:  +381 11 3951339


Vladimir Dobričić was born in Belgrade in 1984. He enrolled at the University of Belgrade – Faculty of Pharmacy in 2003 and graduated in 2009 (average mark 9.87/10.00). He was announced the best graduated student at the study program Pharmacy in 2008/2009 (by the Society of medical biochemists and scientific foundation “prof. dr. Ivan Berkeš”). He was also announced the best graduated student at the University of Belgrade – Faculty of Pharmacy in 2008/2009 by the University of Belgrade. He enrolled at doctoral studies at the University of Belgrade – Faculty of Pharmacy (module: pharmaceutical chemistry) in 2009 and finished it in 2014 (title: “Design, synthesis, physicochemical and biological properties of amides of anti-inflammatory steroid cortienic acids”; defense date: 22nd December 2014). He was a scholar of Republic foundation for the development of scientific and artistic youth and Ministry of education, science and technological development of Republic of Serbia (2009-2011). He has been employed at the Department of Pharmaceutical Chemistry, University of Belgrade – Faculty of Pharmacy since 2011. He teaches Pharmaceutical Chemistry, Pharmaceutical Chemistry 1, Drug design and synthesis and Pharmaceutical Chemistry 1 – English program (theoretical classes), as well as Pharmaceutical Chemistry 1, Pharmaceutical Chemistry 2, Pharmaceutical Chemistry 3, Drug design and synthesis, Pharmaceutical Chemistry 1 – English program, Pharmaceutical Chemistry 3 – English program (practical classes) at integrated academic studies. He also teaches Chemical and biopharmaceutical aspects and computational methods in drug design at doctoral studies and Pharmaceutical-medicinal chemistry at specialist academic studies. His research interest is focused on design, synthesis, investigation of physico-chemical and biological properties of compounds with anti-inflammatory and anticancer activity, as well as on the development and validation of analytical and bioanalytical methods for the quantification of pharmacologically active compounds in pharmaceutical formulations and biological samples. He speaks English and Russian.

  • Dallavalle, S., Dobričić, V., Lazzarato, L., Gazzano, E., Machuqueiro, M., Pajeva, I., Tsakovska, I., Zidar, N., & Fruttero, R. (2020). Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. Drug Resistance Updates, 50, 100682.

  • Knutson, D. E., Kodali, R., Divović, B., Treven, M., Stephen, M. R., Zahn, N. M., Dobričić, V., Huber, A. T., Meirelles, M. A., Verma, R. S., Wimmer, L., Witzigmann, C., Arnold, L. A., Chiou, L-C., Ernst, M., Mihovilovic, M. D., Savić, M. M., Sieghart, W., & Cook, J. M. (2018). Design and synthesis of novel deuterated ligands functionally selective for the γ-aminobutyric acid type A receptor (GABAAR) α6 subtype with improved metabolic stability and enhanced bioavailability. Journal of medicinal chemistry, 61(6), 2422-2446.

  • Hendrickx, L. A., Dobričić, V., Toplak, Ž., Peigneur, S., Mašič, L. P., Tomašič, T., & Tytgat, J. (2020). Design and characterization of a novel structural class of Kv1. 3 inhibitors. Bioorganic Chemistry, 98, 103746.

  • Dobričić, V., Savić, J., Nikolic, K., Vladimirov, S., Vujić, Z., & Brborić, J. (2017). Application of biopartitioning micellar chromatography and QSRR modeling for prediction of gastrointestinal absorption and design of novel β-hydroxy-β-arylalkanoic acids. European Journal of Pharmaceutical Sciences, 100, 280-284.

  • Tubić, B., Dobričić, V., Poljarević, J., Savić, A., Sabo, T., & Marković, B. (2020). Estimation of passive gastrointestinal absorption and membrane retention using PAMPA test, quantitative structure-permeability and quantitative structure-retention relationship analyses of ethylenediamine-N, N'-di-2-(3-cyclohexyl) propanoic acid and 1, 3-propanediamine-N, N'-di-2-(3-cyclohexyl) propanoic acid derivatives. Journal of Pharmaceutical and Biomedical Analysis, 113213.

  • Dobričić, V., Marković, B., Nikolic, K., Savić, V., Vladimirov, S., & Čudina, O. (2014). 17β-carboxamide steroids–in vitro prediction of human skin permeability and retention using PAMPA technique. European Journal of Pharmaceutical Sciences, 52, 95-108.

  • Rupar, J., Dobričić, V., Grahovac, J., Radulović, S., Skok, Ž., Ilaš, J., Aleksić, M., Brborić, J., & Čudina, O. (2020). Synthesis and evaluation of anticancer activity of new 9-acridinyl amino acid derivatives. RSC Medicinal Chemistry1, 11(3), 378-386.

  • Dobričić, V., Drvenica, I., Stančić, A., Mihailović, M., Čudina, O., Bugarski, D., & Ilić, V. (2018). Investigation of metabolic properties and effects of 17β‐carboxamide glucocorticoids on human peripheral blood leukocytes. Archiv der Pharmazie, 351(5), 1700371.

  • Dobričić, V., Jaćević, V., Vučićević, J., Nikolic, K., Vladimirov, S., & Čudina, O. (2017). Evaluation of Biological Activity and Computer‐Aided Design of New Soft Glucocorticoids. Archiv der Pharmazie, 350(5), 1600383.

  • Dobričić, V., Turković, N., Ivković, B., Csuvik, O., & Vujić, Z. Evaluation of the lipophilicity of chalcones by RP-TLC and computational methods. JPC – Journal of Planar Chromatography – Modern TLC (2020) 33:245–253.